Success rates for new drugs entering clinical testing in the United States
- 1 July 1995
- journal article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 58 (1) , 1-14
- https://doi.org/10.1016/0009-9236(95)90066-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Research and Development Costs for New Drugs by Therapeutic CategoryPharmacoEconomics, 1995
- New drug development in the United States from 1963 to 1992Clinical Pharmacology & Therapeutics, 1994
- New drug development in the United States from 1963 to 1990Clinical Pharmacology & Therapeutics, 1991
- Cost of innovation in the pharmaceutical industryJournal of Health Economics, 1991
- New drug development in the United States, 1963 through 1984Clinical Pharmacology & Therapeutics, 1988
- Success rates in the United States drug development systemClinical Pharmacology & Therapeutics, 1984
- Composition of R and D Expenditures: Relationship to Size of Firm, Concentration, and Innovative OutputThe Review of Economics and Statistics, 1981
- Development of new drugs originated and acquired by United States–owned pharmaceutical firms, 1963-1976*Clinical Pharmacology & Therapeutics, 1980
- The rate of development of new drugs in the United States, 1963 through 1975Clinical Pharmacology & Therapeutics, 1978